China ranks third in global index for AI competitiveness in life sciences
China has secured third place globally in a new index assessing competitiveness in Artificial Intelligence (AI) for life sciences, according to the Global AI Competitiveness Index released by Deep Knowledge Group. The index ranks countries based on their AI capabilities in biotechnology, healthcare, and longevity, with China trailing only the United States and the United Kingdom.

Briefing Summary
AI-generatedChina has secured third place globally in a new index assessing competitiveness in Artificial Intelligence (AI) for life sciences, according to the Global AI Competitiveness Index released by Deep Knowledge Group. The index ranks countries based on their AI capabilities in biotechnology, healthcare, and longevity, with China trailing only the United States and the United Kingdom. This ranking reflects China's significant strengths in AI, biotechnology, and talent. The report highlights the growing trend of applying AI beyond general models into specialized, data-intensive sectors like drug discovery and diagnostics. China's National Health Commission and other government bodies have also recently launched a plan to expedite AI integration within its healthcare system, underscoring the nation's strategic focus on this area.
Article analysis
Model · rule-basedKey claims
4 extractedChina's score of 85.3 reflects major scale in AI, biotechnology and talent.
China's National Health Commission and four other agencies rolled out a plan to accelerate AI adoption across the healthcare sector.
The Global AI Competitiveness Index ranked China behind only the US and UK.
China ranked third in a new global index measuring competitiveness in AI for biotechnology, healthcare and longevity.